Giant Biogene Holding Co (HKSE:02367) Beta: 1.1055 (As of Sep. 17, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02367 Giant Biogene Holding Co Ltd HKSE:02367
85 GF Score
Price HK$24.46
GF Value HK$68.03
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Giant Biogene Holding Co Beta?

Giant Biogene Holding Co HKSE:02367 +1.24% 85 Beta is 1.1055 as of Sep. 17, 2026. GuruFocus rates HKSE:02367 with a GF Score™ of 85/100 and a GF Value™ of HK$68.03 (Possible Value Trap). The stock has 4 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-09-17), Giant Biogene Holding Co's Beta is 1.1055.


Giant Biogene Holding Co  (HKSE:02367) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Giant Biogene Holding Co Beta Related Terms


Giant Biogene Holding Co Beta Historical Data

* Premium members only.

The historical data trend for Giant Biogene Holding Co's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Giant Biogene Holding Co Beta Chart

Giant Biogene Holding Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.82

Giant Biogene Holding Co Semi-Annual Data
Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Beta Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.82 0.90

HKSE:02367 vs PG, CL, EL: Beta Comparison

For the Household & Personal Products subindustry, Giant Biogene Holding Co's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Giant Biogene Holding Co Beta vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Giant Biogene Holding Co's Beta distribution charts can be found below:

* The bar in red indicates where Giant Biogene Holding Co's Beta falls into.


HKSE:02367
85GF Score
Giant Biogene Holding Co Ltd HKSE:02367
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Giant Biogene Holding Co Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 1.1055 mean?
Giant Biogene Holding Co (HKSE:02367) has a Beta of 1.1055 as of Sep. 17, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Giant Biogene Holding Co and its competitors.
Is Giant Biogene Holding Co's Beta too high?
Giant Biogene Holding Co's current Beta is 1.1055. Overall, Giant Biogene Holding Co has a GF Score™ of 85/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Giant Biogene Holding Co's Beta compare to PG and CL?
Giant Biogene Holding Co's Beta of 1.1055 can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Consumer Packaged Goods company?
A good Beta depends on the Consumer Packaged Goods industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Giant Biogene Holding Co and its competitors. Giant Biogene Holding Co's current Beta is 1.1055. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Giant Biogene Holding Co stock overvalued right now?
Based on GuruFocus' analysis, Giant Biogene Holding Co (HKSE:02367) is currently considered Possible Value Trap. The stock's GF Value™ is HK$68.03, compared to a current price of HK$24.46 — trading 64% below its estimated fair value. The current Beta is 1.1055. Giant Biogene Holding Co's overall GF Score™ is 85/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Giant Biogene Holding Co (HKSE:02367), the current Beta is 1.1055 as of Sep. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Giant Biogene Holding Co (HKSE:02367) Overvalued in 2026?

Based on GuruFocus' analysis, Giant Biogene Holding Co stock appears to be undervalued. The current stock price of HK$24.46 is trading 64% below its estimated GF Value™ of HK$68.03. GuruFocus considers Giant Biogene Holding Co to be Possible Value Trap.

Key valuation signals for HKSE:02367:

  • Beta: 1.1055
  • GF Value™: HK$68.03 vs. price of HK$24.46 (64% below fair value)
  • GF Score™: 85/100 with 4 warning signs

No single metric tells the full story. See the HKSE:02367 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Giant Biogene Holding Co Business Description

Address No. 1855, Shanglin Yuan 7th Road, Chang’an District, Shaanxi Province, Xi’an, CHN
Giant Biogene Holding Co Ltd designs, develops, and manufactures professional skin treatment products with recombinant collagen as the key bioactive ingredient. The company also develops and manufactures rare ginsenoside technology-based functional foods. The company utilizes proprietary synthetic biology technology to develop & manufacture multiple types of recombinant collagen & rare ginsenosides in-house. Bioactive ingredients offer a wealth of beauty & health properties such as skin repair, anti-aging, whitening, moisturizing, & immunity improvement, with a broad range of applications in the beauty & health sectors. The group is organised into a single business unit that mainly includes the research, development, manufacture, & sale of bioactive material-based beauty & health products.
85GF Score

Get the complete analysis for HKSE:02367

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$24.46
Price
HK$68.03
GF Value